Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial

Indian Journal of Pediatrics
N B Mathur, A Murugesan

Abstract

To compare the effect of 4 day course (study group) with 7 day course (control group) of antibiotic treatment in neonatal pneumonia, on treatment success rate. This randomized controlled trial was conducted in a tertiary teaching hospital. Seventy, term and near-term neonates with pneumonia who had clinical remission by 48 h of antibiotic therapy were included. The neonates were randomized to receive a total of 4 d of antibiotics (Group 1) or 7 d of antibiotics (Group 2). The outcome measure was treatment failure in each group within 3 d of discharge. The treatment success rate of both the groups was 100%. There was a significant reduction in the duration of hospital stay (p < 0.001), antibiotic usage (p < 0.001), and cost (p < 0.001) in the 4 d group. On follow up till 28 d of enrollment, no infective morbidity was found in either group. For term and near-term neonates who become clinically asymptomatic within 48 h of antibiotic therapy, 4 d of antibiotic therapy is as effective and safe as 7 d of antibiotic therapy, with significant reduction in hospital stay, antibiotic usage and cost.

References

May 1, 1993·Archives of Disease in Childhood·A T BangJ M Solanki
Feb 1, 1997·Acta Paediatrica·G MonneretJ Bienvenu
Apr 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ChiesaL Pacifico
Sep 4, 1998·BMJ : British Medical Journal·R WiseM Sprenger
Nov 15, 2000·Journal of Perinatology : Official Journal of the California Perinatal Association·W D EngleW H Frawley
Jul 29, 2003·Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses·Joan M Hengst
Apr 23, 2005·Archives of Disease in Childhood. Fetal and Neonatal Edition·T Duke
Apr 11, 2006·American Journal of Respiratory and Critical Care Medicine·Mirjam Christ-CrainBeat Müller
Aug 3, 2006·Pediatrics·C Michael CottenUNKNOWN National Institute for Child Health and Human Development Neonatal Research Network
Oct 13, 2006·Journal of Tropical Pediatrics·G ChowdharyA Narang
Feb 27, 2010·Journal of Tropical Pediatrics·Geeta GathwalaUma Chaudhary
Dec 14, 2011·International Journal of Pediatrics·Sindhu SivanandanKamala Swarnam
Jul 2, 2014·Annals of Laboratory Medicine·Michael Meisner
Jan 1, 2014·Current Treatment Options in Infectious Diseases·Andrew M Morris

❮ Previous
Next ❯

Citations

Jul 30, 2018·Indian Journal of Pediatrics·B Vishnu Bhat, B Adhisivam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Journal of Perinatology : Official Journal of the California Perinatal Association
W A EngleW H Frawley
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Newton BanupriyaSubash Chandra Parija
© 2022 Meta ULC. All rights reserved